Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
ZyVersa Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
8-K
| Quarterly results |
| 07/26/2023 |
8-K
| Quarterly results |
| 05/19/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/03/2023 |
8-K
| Quarterly results |
| 03/10/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 01/27/2023 |
8-K
| Other Events Interactive Data |
| 01/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/13/2022 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failur...|
Docs:
|
"SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF",
"Second Amended and Restated Bylaws of ZyVersa Therapeutics, Inc. Article I — Corporate Offices 1.1 Registered Office. The address of the registered office of ZyVersa Therapeutics, Inc. in the State of Delaware, and the name of its registered agent at such address, shall be as set forth in the Corporation’ s amended and restated certificate of incorporation, as the same may be amended and/or restated from time to time . 1.2 Other Offices. The Corporation may have additional offices at any place or places, within or outside the State of Delaware, as the Corporation’ s board of directors may from time to time establish or as the business of the Corporation may require. Article II — Meetings of Stockholders 2.1 Place of Meetings. Meetings of stockholders shall be held at any place within or ou...",
"LARKSPUR HEALTH ACQUISITION CORP. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Daniel J. O’ Connor, do hereby certify that: 1. He is the Chief Executive Officer and Secretary, respectively, of Larkspur Health Acquisition Corp., a Delaware corporation . 2. The Corporation is authorized to issue 1,000,000 shares of preferred stock, none of which have been issued. 3. The following resolutions were duly adopted by the board of directors of the Corporation : WHEREAS, the amended and restated certificate of incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting of 1,000,000 shares, $0.0001 par val...",
"LARKSPUR HEALTH ACQUISITION CORP. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Daniel J. O’ Connor, do hereby certify that: 1. He is the Chief Executive Officer and Secretary, respectively, of Larkspur Health Acquisition Corp., a Delaware corporation . 2. The Corporation is authorized to issue 1,000,000 shares of preferred stock, none of which have been issued. 3. The following resolutions were duly adopted by the board of directors of the Corporation : WHEREAS, the amended and restated certificate of incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting of 1,000,000 shares, $0.0001 par val...",
"COMMON STOCK PURCHASE WARRANT LARKSPUR HEALTH ACQUISITION CORP. Warrant Shares: [_______] Initial Exercise Date: December 12, 2022 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, [_____________] or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and on or prior to 5:00 p.m. on December 12, 2027 but not thereafter, to subscribe for and purchase from Larkspur Health Acquisition Corp., a Delaware corporation , up to [______] 1 shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2 . Section 1 . Definitions . Capitalized terms used and not otherwise defined he...",
"ZYVERSA THERAPEUTICS, INC. WARRANT CERTIFICATE FOR VALUE RECEIVED, ZyVersa Therapeutics, Inc., a Florida corporation , hereby certifies that [____], or its registered transferees, successors or assigns holding all or a part of this Warrant being referred to as a “Holder”), is the registered Holder of this Warrant to subscribe for the purchase of Warrant Shares 6 , as adjusted from time to time as provided herein, during the Exercise Period , all subject to the following terms and conditions. This Warrant is being issued pursuant to the terms of that certain Subscription Agreement dated , 2022 . Terms not otherwise defined herein shall have the meanings given to such terms in the Subscription Agreement. For purposes of this Warrant the following terms shall have the following meanings: “Agg...",
"AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT",
"REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT , dated as of December 12, 2022, is by and among Larkspur Health Acquisition Corp., a Delaware corporation , and the undersigned Purchasers . RECITALS A. In connection with the Securities Purchase Agreement by and among the parties hereto, dated as of July 20, 2022 , the Company has agreed, upon the terms and subject to the conditions of the Securities Purchase Agreement, to issue and sell to each Purchaser shares of Preferred Stock which will be convertible into shares of Common Stock in accordance with the terms of the Certificate of Designation and the Warrants which will be exercisable to purchase Warrant Shares in accordance with the terms of the Warrants. B. To induce the Purchasers to consummate the transactions cont...",
"REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT , dated as of December 12, 2022, is by and among Larkspur Health Acquisition Corp., a Delaware corporation , and the undersigned Purchasers . RECITALS A. In connection with the Securities Purchase Agreement by and among the parties hereto, dated as of December 12, 2022 , the Company has agreed, upon the terms and subject to the conditions of the Securities Purchase Agreement, to issue and sell to each Purchaser shares of Preferred Stock which will be convertible into shares of Common Stock in accordance with the terms of the Certificate of Designation . B. To induce the Purchasers to consummate the transactions contemplated by the Securities Purchase Agreement, the Company has agreed to provide certain registration rights u..." |
|
| 12/09/2022 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits Interac... |
| 02/11/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/08/2022 |
8-K
| Quarterly results |
| 12/30/2021 |
8-K
| Quarterly results |
| 12/23/2021 |
8-K
| Quarterly results |
|
|